Medicare.gov: the official U.S. government site for Medicare

Posted by:  :  Category: Medicare

The page could not be loaded. The Medicare.gov Home page currently does not fully support browsers with "JavaScript" disabled. Please note that if you choose to continue without enabling "JavaScript" certain functionalities on this website may not be available.
Source: medicare.gov

Medicare Rebates: How Not to Protect Taxpayers nor Lower Drug Prices

The latest example is a proposal to put Medicare Part D under the same type of price controls that have driven up drug prices under Medicaid over the last several decades. Critics of Medicare Part D should be required to pass the following test before proposing to blow up the program with price controls: what other program, in the history of government, has come in dramatically under cost projections?
Source: townhall.com

Require Manufacturers to Pay a Minimum Rebate on Drugs Covered Under Part D of Medicare for Low

Medicare Part D is a voluntary, federally subsidized prescription drug benefit program delivered to beneficiaries by private-sector plans. Federal subsidies for Part D drug benefits, net of the premiums paid by enrollees, totaled about $63 billion in calendar year 2013. (Federal subsidies include payments to stand-alone prescription drug plans and Medicare Advantage plans; they exclude subsidies to employers for prescription drug coverage provided outside of Part D for retirees.) Private drug plans can limit their costs for providing benefits to their Part D enrollees by negotiating to receive rebates from manufacturers of brand-name drugs in return for charging enrollees smaller copayments for those drugs. The negotiation of rebate amounts is a business strategy for a Part D plan that is most effective when a few manufacturers’ drugs are competing for market share in the treatment of a particular medical condition. The Congressional Budget Office estimates that in 2013, manufacturers’ rebates paid to Part D plans amounted to about 18 percent of gross spending on all brand-name drugs under Part D.
Source: cbo.gov

Australian Government rebate on Private Health Insurance

This information was printed Wednesday 31 May 2017 from humanservices.gov.au/customer/services/medicare/australian-government-rebate-private-health-insurance It may not include all of the relevant information on this topic. Please consider any relevant site notices at humanservices.gov.au/siteinformation when using this material.
Source: gov.au

Related posts:

  1. Require Manufacturers to Pay a Minimum Rebate on Drugs Covered Under Part D of Medicare for Low
  2. Medicare.gov: the official U.S. government site for Medicare
  3. Medicare.gov: the official U.S. government site for Medicare
  4. Medicare.gov: the official U.S. government site for Medicare
  5. Medicare.gov: the official U.S. government site for Medicare

Comments are closed.